KDR and central nervous system cancer: Histological examination of glioma bioptic specimens of patients who died after receiving treatment with cediranib, an inhibitor of VEGFR-2 (di Tomaso et al., 2011), or bevacizumab (de Groot et al., 2010) demonstrated that glioma cells grow around pre-existing vessels in a non-angiogenic fashion.